FEIM Frequency Electronics, Inc.
Frequency Electronics, Inc., together with its subsidiaries, engages in the design, development, manufacture, marketing, and sale of precision time and frequency control products and components for microwave integrated circuit applications. The company operates through two segments, FEI-NY and FEI-Zyfer. The FEI-NY segment offers precision time and frequency control products for communication satellites, terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military, as well as provides designing and technical support for the satellite business. The FEI-Zyfer segment provides global positioning system technologies for systems and subsystems for secure communications, government and commercial, and other locator applications; and engages in the sale and support of wireline telecommunications products, such as US5G. It operates in the United States, Europe, and Asia. Frequency Electronics, Inc. was founded in 1961 and is headquartered in Mitchel Field, New York.…
Industry Peers
Communication EquipmentKey Statistics
About Frequency Electronics (NASDAQ: FEIM)
›
Frequency Electronics (NASDAQ: FEIM) is listed on Nasdaq, where its shares trade in USD. It belongs to the Communication Equipment industry, part of the Technology sector, and reports about 232 employees.
The shares were at 60.32 USD on 19 November 2026, up 82.0% over 52 weeks. Its 52-week range is 26.05 USD to 89.76 USD: the price is 32.8% below the high and 131.6% above the low.
At a market capitalisation of 680.00M USD, it trades at 241.3 times trailing earnings and 31.4 times forward earnings. The median trailing P/E of its 16 largest Communication Equipment peers is 31.4, a premium of 669% for FEIM.
Frequency Electronics reports return on equity of -1.6%, an operating margin of 8.3% and revenue up 69.8% year over year.
It holds more cash than debt, a net cash position of 54.45M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 2 analysts cover the stock; their mean price target of 95.50 USD is 58.3% above the current price. The next earnings report is expected on 10 December 2026.